Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30575490

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Dec 20
First author
Conroy T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2018 Dec 20;379(25):2463-2464. doi: 10.1056/NEJMe1813684.
    note
    Source null
    related pmid
    30575492
    relationship
    Comment in
  2. citation
    Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):140. doi: 10.1038/s41575-019-0112-3.
    note
    Source null
    related pmid
    30675024
    relationship
    Comment in
  3. citation
    Strahlenther Onkol. 2019 Jun;195(6):570-572. doi: 10.1007/s00066-019-01449-2.
    note
    Source null
    related pmid
    30847534
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Mar 21;380(12):1187-1188. doi: 10.1056/NEJMc1900712.
    note
    Source null
    related pmid
    30893543
    relationship
    Comment in
  5. citation
    Future Oncol. 2019 Jun;15(17):1947-1950. doi: 10.2217/fon-2019-0136.
    note
    Source null
    related pmid
    31185748
    relationship
    Comment in
  6. citation
    World J Gastroenterol. 2019 Jun 21;25(23):2839-2845. doi: 10.3748/wjg.v25.i23.2839.
    note
    Source null
    related pmid
    31249443
    relationship
    Comment in
  7. citation
    Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):1-10. doi: 10.1016/j.ijrobp.2019.04.037.
    note
    Source null
    related pmid
    31422802
    relationship
    Comment in
  8. citation
    Pancreas. 2020 Jan;49(1):e11. doi: 10.1097/MPA.0000000000001449.
    note
    Source null
    related pmid
    31856098
    relationship
    Comment in
  9. citation
    JAMA Oncol. 2023 Mar 1;9(3):435-436. doi: 10.1001/jamaoncol.2022.7358.
    note
    Source null
    related pmid
    36701148
    relationship
    Comment in

Authors and identifiers

  1. name
    Conroy T
    type
    Author
  2. name
    Hammel P
    type
    Author
  3. name
    Hebbar M
    type
    Author
  4. name
    Ben Abdelghani M
    type
    Author
  5. name
    Wei AC
    type
    Author
  6. name
    Raoul JL
    type
    Author
  7. name
    Choné L
    type
    Author
  8. name
    Francois E
    type
    Author
  9. name
    Artru P
    type
    Author
  10. name
    Biagi JJ
    type
    Author
  11. name
    Lecomte T
    type
    Author
  12. name
    Assenat E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Conroy T
    type
    Author
  2. name
    Hammel P
    type
    Author
  3. name
    Hebbar M
    type
    Author
  4. name
    Ben Abdelghani M
    type
    Author
  5. name
    Wei AC
    type
    Author
  6. name
    Raoul JL
    type
    Author
  7. name
    Choné L
    type
    Author
  8. name
    Francois E
    type
    Author
  9. name
    Artru P
    type
    Author
  10. name
    Biagi JJ
    type
    Author
  11. name
    Lecomte T
    type
    Author
  12. name
    Assenat E
    type
    Author
bibliography ids
  1. nci-bib-acaac7cc0fd46172cf57c76a
book metadata
content sha256
d84bf437cea78a32fffdc582263ea7f57ce62ddd1801e18aa58352fe8bb44bd1
document type
citation
dois
  1. 10.1056/NEJMoa1809775
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:30575490
immutable id
pubmed:30575490@d84bf437cea78a32fffdc582263ea7f57ce62ddd1801e18aa58352fe8bb44bd1
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
25
name
The New England journal of medicine
nlm unique id
0255562
pages
2395-2406
volume
379
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2018 Dec 20;379(25):2463-2464. doi: 10.1056/NEJMe1813684.
    note
    Source null
    related pmid
    30575492
    relationship
    Comment in
  2. citation
    Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):140. doi: 10.1038/s41575-019-0112-3.
    note
    Source null
    related pmid
    30675024
    relationship
    Comment in
  3. citation
    Strahlenther Onkol. 2019 Jun;195(6):570-572. doi: 10.1007/s00066-019-01449-2.
    note
    Source null
    related pmid
    30847534
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Mar 21;380(12):1187-1188. doi: 10.1056/NEJMc1900712.
    note
    Source null
    related pmid
    30893543
    relationship
    Comment in
  5. citation
    Future Oncol. 2019 Jun;15(17):1947-1950. doi: 10.2217/fon-2019-0136.
    note
    Source null
    related pmid
    31185748
    relationship
    Comment in
  6. citation
    World J Gastroenterol. 2019 Jun 21;25(23):2839-2845. doi: 10.3748/wjg.v25.i23.2839.
    note
    Source null
    related pmid
    31249443
    relationship
    Comment in
  7. citation
    Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):1-10. doi: 10.1016/j.ijrobp.2019.04.037.
    note
    Source null
    related pmid
    31422802
    relationship
    Comment in
  8. citation
    Pancreas. 2020 Jan;49(1):e11. doi: 10.1097/MPA.0000000000001449.
    note
    Source null
    related pmid
    31856098
    relationship
    Comment in
  9. citation
    JAMA Oncol. 2023 Mar 1;9(3):435-436. doi: 10.1001/jamaoncol.2022.7358.
    note
    Source null
    related pmid
    36701148
    relationship
    Comment in
outcomes validated
false
pmid
30575490
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
14e783bef70d2f43443dc9d1f352e2f66487bbf5f5a3575e9c5fcd4e60e38809
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2018 Dec 20
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30575490/
title
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

Preserved source evidence · Not medical advice